Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Recruiting 5Not yet recruiting 2Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 10Gastrointestinal 6Head & Neck 5Thoracic 3Sarcoma 2Lymphoid 2Classical hematology 2Other hematologic neoplasm 1Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 374Head and Neck Neoplasms 355Nasopharyngeal Carcinoma 142Thyroid Neoplasms 124Carcinoma, Non-Small-Cell Lung 94Mouth Neoplasms 85Melanoma 76Breast Neoplasms 75Oropharyngeal Neoplasms 72Colorectal Neoplasms 70Uterine Cervical Neoplasms 66Lung Neoplasms 66Neoplasms 64Ovarian Neoplasms 61Prostatic Neoplasms 52Neoplasm Metastasis 52Stomach Neoplasms 49Pancreatic Neoplasms 48Carcinoma, Squamous Cell 47Triple Negative Breast Neoplasms 44Endometrial Neoplasms 43Esophageal Neoplasms 42Laryngeal Neoplasms 40Carcinoma, Renal Cell 38Thyroid Nodule 37Urinary Bladder Neoplasms 36Sarcoma 34Recurrence 30Carcinoma 29Nasopharyngeal Neoplasms 27

Interventions

toripalimab 1nimotuzumab 1Radiotherapy 1Neoadjuvant Therapy 1Immunotherapy 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Pathologic Complete Response × Head & Neck × Clear all
NCT07353723 2026-01-20

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Tang-Du Hospital

Phase 2 Recruiting
10 enrolled
Head & Neck

Pathologic Complete Response, Head and Neck Neoplasms

NCT07328841 2026-01-09

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

Sun Yat-sen University

Phase 3 Recruiting
456 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Pathologic Complete Response

NCT07328854 2026-01-09

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Recruiting
346 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Pathologic Complete Response

NCT06811844 2025-07-01

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting
208 enrolled
Head & Neck

Pathologic Complete Response, Nasopharyngeal Neoplasms

NCT06182657 2024-02-08

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

Jiangxi Provincial Cancer Hospital

Recruiting
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡